We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
OCT Clinical is happy to announce that this year our team is going to attend BIOCHINA International Convention 2024 as an exhibitor.
BIOCHINA sets sail with three major systems - exhibitions, conferences and events, with a scale of 30,000 people, 550 exhibitors, and 500 academic speeches, and aims to further develop innovative technologies and product development in the pharmaceutical industry. OCT Clinical is thrilled to be a part of this significant event!
We'll be waiting for you at our booth No. SC057 on March 14-16, 2024, the Suzhou International Expo Center.
Should you already have any particular requests, reach out to Polina Nabieva, Business Development Manager, to book a meeting with OCT Team in advance at pnabieva@oct-clinicaltrials.com
See you in Suzhou!
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.